These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29281738)

  • 1. Correction: Correlation of serum cartilage oligometric matrix protein (COMP) and interleukin-16 (IL-16) levels with disease severity in primary knee osteoarthritis: A pilot study in a Malaysian population.
    Das Gupta E; Ng WR; Wong SF; Bhurhanudeen AK; Yeap SS
    PLoS One; 2017; 12(12):e0190542. PubMed ID: 29281738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum levels of non-collagenous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runners.
    Neidhart M; Müller-Ladner U; Frey W; Bosserhoff AK; Colombani PC; Frey-Rindova P; Hummel KM; Gay RE; Häuselmann H; Gay S
    Osteoarthritis Cartilage; 2000 May; 8(3):222-9. PubMed ID: 10806050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cartilage oligomeric matrix protein (COMP) in knee osteoarthritis: a novel diagnostic and prognostic biomarker.
    Verma P; Dalal K
    J Orthop Res; 2013 Jul; 31(7):999-1006. PubMed ID: 23423905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project.
    Clark AG; Jordan JM; Vilim V; Renner JB; Dragomir AD; Luta G; Kraus VB
    Arthritis Rheum; 1999 Nov; 42(11):2356-64. PubMed ID: 10555031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum cartilage oligomeric matrix protein (COMP) levels in knee osteoarthritis in a Brazilian population: clinical and radiological correlation.
    Fernandes FA; Pucinelli ML; da Silva NP; Feldman D
    Scand J Rheumatol; 2007; 36(3):211-5. PubMed ID: 17657676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cartilage oligomeric matrix protein in serum in systemic lupus erythematosus and knee osteoarthritis. Preliminary communication.
    Wisłowska M; Jabłońska B
    Rheumatol Int; 2005 Jun; 25(5):373-8. PubMed ID: 15739097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis.
    Wisłowska M; Jabłońska B
    Clin Rheumatol; 2005 Jun; 24(3):278-84. PubMed ID: 15940561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years.
    Sharif M; Kirwan JR; Elson CJ; Granell R; Clarke S
    Arthritis Rheum; 2004 Aug; 50(8):2479-88. PubMed ID: 15334461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis.
    Vilím V; Vytásek R; Olejárová M; Machácek S; Gatterová J; Procházka B; Kraus VB; Pavelka K
    Osteoarthritis Cartilage; 2001 Oct; 9(7):612-8. PubMed ID: 11597173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of sonographic severity with biochemical markers of synovium and cartilage in knee osteoarthritis patients.
    Jung YO; Do JH; Kang HJ; Yoo SA; Yoon CH; Kim HA; Cho CS; Kim WU
    Clin Exp Rheumatol; 2006; 24(3):253-9. PubMed ID: 16870091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of cartilage oligomeric matrix protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis.
    Andersson ML; Thorstensson CA; Roos EM; Petersson IF; Heinegård D; Saxne T
    BMC Musculoskelet Disord; 2006 Dec; 7():98. PubMed ID: 17156423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study of serum cartilage oligomeric matrix protein and matrix metalloproteinase-3 concentration in osteoarthritic rabbit models].
    Li GY; Zhang RF; Pan L; Zhang X; Zhang K; Wang GC; Wu DH; Ma L
    Zhonghua Nei Ke Za Zhi; 2011 May; 50(5):416-9. PubMed ID: 21624227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritis.
    Andersson ML; Petersson IF; Karlsson KE; Jonsson EN; Månsson B; Heinegård D; Saxne T
    Ann Rheum Dis; 2006 Nov; 65(11):1490-4. PubMed ID: 16707535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein.
    Senolt L; Braun M; Olejárová M; Forejtová S; Gatterová J; Pavelka K
    Ann Rheum Dis; 2005 Jun; 64(6):886-90. PubMed ID: 15897309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Running decreases knee intra-articular cytokine and cartilage oligomeric matrix concentrations: a pilot study.
    Hyldahl RD; Evans A; Kwon S; Ridge ST; Robinson E; Hopkins JT; Seeley MK
    Eur J Appl Physiol; 2016 Dec; 116(11-12):2305-2314. PubMed ID: 27699484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum levels of cartilage oligomeric matrix protein in the diagnosis of knee osteoarthritis].
    Li H; Wang D; Wu ZQ; Zhong JM; Yuan YJ
    Zhongguo Gu Shang; 2012 May; 25(5):380-3. PubMed ID: 22870681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The heritable determinants of cartilage oligomeric matrix protein.
    Williams FM; Andrew T; Saxne T; Heinegard D; Spector TD; MacGregor AJ
    Arthritis Rheum; 2006 Jul; 54(7):2147-51. PubMed ID: 16802351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synovial fluid levels of bradykinin correlate with biochemical markers for cartilage degradation and inflammation in knee osteoarthritis.
    Bellucci F; Meini S; Cucchi P; Catalani C; Nizzardo A; Riva A; Guidelli GM; Ferrata P; Fioravanti A; Maggi CA
    Osteoarthritis Cartilage; 2013 Nov; 21(11):1774-80. PubMed ID: 23942063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vibration training intervention to maintain cartilage thickness and serum concentrations of cartilage oligometric matrix protein (COMP) during immobilization.
    Liphardt AM; Mündermann A; Koo S; Bäcker N; Andriacchi TP; Zange J; Mester J; Heer M
    Osteoarthritis Cartilage; 2009 Dec; 17(12):1598-603. PubMed ID: 19747585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.